NCT00330785
- Conditions
- Cardiovascular Diseases, Dyslipidemia, Dyslipidemias, +5 more
- Locations
-
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada
- Pfizer Investigational Site Calgary, Alberta, Canada